| Title | Evidence and Policy |
| Abbreviation | Evid. Policy |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Social Sciences (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Orthopedics and Sports Medicine (Q2); Physiology (Q2) |
| h-index | 40 |
| Overall Rank/Ranking | 5572 |
| SCImago Journal Rank (SJR) | 0.839 |
| Impact Score | 2.33 |
| Publisher | Policy Press |
| Country | United Kingdom |
| ISSN | 17442648 |
| Best Quartile | Q1 |
| Coverage History | 2006-2022 |
Evidence and Policy is a journal covering the technologies/fields/categories related to Social Sciences (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Orthopedics and Sports Medicine (Q2); Physiology (Q2). It is published by Policy Press. The overall rank of Evidence and Policy is 5572. According to SCImago Journal Rank (SJR), this journal is ranked 0.839. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 40. The best quartile for this journal is Q1.
The ISSN of Evidence and Policy journal is 17442648. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Evidence and Policy is cited by a total of 332 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Evidence and Policy is 2.33, which is computed in 2023 as per its definition. Evidence and Policy IF is decreased by a factor of 0.11 and approximate percentage change is -4.51% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Evidence and Policy is 2.33. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.33 |
| 2021 | 2.44 |
| 2020 | 1.34 |
| 2019 | 1.44 |
| 2018 | 1.69 |
| 2017 | 1.05 |
| 2016 | 0.91 |
| 2015 | 1.47 |
| 2014 | 1.05 |
Evidence and Policy has an h-index of 40. It means 40 articles of this journal have more than 40 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Evidence and Policy is 17442648. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Evidence and Policy is 5572. According to SCImago Journal Rank (SJR), this journal is ranked 0.839. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.839 |
| 2021 | 0.615 |
| 2020 | 0.616 |
| 2019 | 0.496 |
| 2018 | 0.777 |
| 2017 | 0.496 |
| 2016 | 0.513 |
| 2015 | 0.625 |
| 2014 | 0.746 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5572 |
| 2021 | 8029 |
| 2020 | 8202 |
| 2019 | 9851 |
| 2018 | 6096 |
| 2017 | 9275 |
| 2016 | 9084 |
| 2015 | 7596 |
| 2014 | 6199 |
Evidence and Policy is published by Policy Press. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2006-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Evidence and Policy is Evid. Policy. This abbreviation ('Evid. Policy') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Social Sciences (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Orthopedics and Sports Medicine (Q2); Physiology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Evidence and Policy latest impact IF is 2.33. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.44 (2021) and 0.91 (2016), respectively, in the last 9 years. Moreover, its average IS is 1.52 in the previous 9 years.
The Evidence and Policy has an SJR (SCImago Journal Rank) of 0.839, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.839 in 2022 and the lowest being 0.496 in 2019. Furthermore, the average SJR of the Evidence and Policy over the previous 9-year period stands at 1.52.
The latest h-index of the Evidence and Policy is 40.
The Evidence and Policy is published by the Policy Press, with its country of publication being the United Kingdom.
The Evidence and Policy is currently ranked 5572 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 5572 in 2022 and its lowest position of 9851 in 2019.
The standard ISO4 abbreviation for the Evidence and Policy is Evid. Policy.
Evidence and Policy is classified as a journal that the Policy Press publishes.
The Evidence and Policy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Evidence and Policy is assigned the following International Standard Serial Numbers (ISSN): 17442648.
The best quartile for the Evidence and Policy is Q1 (2022).
The Evidence and Policy coverage history can be summarized as follows: 2006-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| World Englishes | journal | 4960 | Wiley-Blackwell | 60 | 1.97 |
| Marine Biology Research | journal | 13573 | Taylor and Francis Ltd. | 42 | 1.06 |
| Asian Textile Journal | trade journal | 27455 | G P S Kwatra | 10 | 0.01 |
| Proteomics - Clinical Applications | journal | 9140 | Wiley-VCH Verlag | 59 | 2.02 |
| Physics and Chemistry of the Earth | journal | 12927 | Pergamon Press Ltd. | 33 | 0.00 |
| Poljoprivreda | journal | 20724 | Faculty of Agriculture in Osijek | 14 | 0.67 |
| Metascience | journal | 13645 | Springer Nature | 3 | 0.13 |
| Clinical Interventions in Aging | journal | 4777 | Dove Medical Press Ltd. | 96 | 3.57 |
| International Journal of Organizational Analysis | journal | 8713 | Emerald Group Publishing Ltd. | 36 | 3.53 |
| Innovations in Pharmaceutical Technology | trade journal | 26994 | Samedan Ltd | 9 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.33 |
| 2021 | 2.44 |
| 2020 | 1.34 |
| 2019 | 1.44 |
| 2018 | 1.69 |
| 2017 | 1.05 |
| 2016 | 0.91 |
| 2015 | 1.47 |
| 2014 | 1.05 |
